JPMorgan Downgrades Novo Nordisk (NVO) to Underweight, Losing Ground to Competition

JPMorgan downgraded Novo Nordisk (NYSE: NVO) from Neutral to Underweight. Analysts said the company was losing to rivals and investors were in "denial" about deteriorating fundamentals.

For an analyst ratings summary and ratings history on Novo Nordisk click here. For more ratings news on Novo Nordisk click here.

Shares of Novo Nordisk closed at $174.88 yesterday.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Morgan Stanley Double Downgrades AU Optronics (2409:TT) (AUO) to Underweight
• Wolfe Research Downgrades Warner Brothers Discovery (WBD) to Underperform, 'out of concern that an incipient advertising downturn put guidance at risk'
• Citi Downgrades UBS AG (UBSG:SW) (UBS) to Neutral